Core Viewpoint - The company reported stable revenue and a slight increase in net profit for Q1 2025, indicating resilience in its financial performance despite market fluctuations [1] Financial Performance - Q1 2025 revenue was CNY 1.1 billion, unchanged year-on-year, while net profit attributable to shareholders was CNY 100 million, up 5% year-on-year [1] - The company's gross margin improved by 0.9 percentage points to 20.8%, with net profit margin increasing by 0.5 percentage points to 9.6% [1] Sales and Orders - Short-term fluctuations in domestic orders were noted, with yarn shipments performing better than orders [2] - Sales revenue for wool yarn is estimated to remain stable, while cashmere yarn sales are expected to grow by 15% to 20% year-on-year [2] - The company anticipates a decline in sales for wool tops due to other business demand conditions [2] Capacity Expansion - The company is continuing its capacity expansion plans, with production expected to increase across various yarn types [3] - By 2024, the company plans to produce 16,800 tons of wool yarn, a 17% increase year-on-year, and is actively working on global capacity layout [3] - Inventory levels increased by 20.7% year-on-year to CNY 2.26 billion, impacting short-term cash flow [3] Long-term Outlook - The company is focused on long-term asset construction, with stable performance expected in 2025 and ongoing competitive strength improvements [4] - Revenue and net profit are projected to grow steadily in 2025, with net profits estimated at CNY 433 million, CNY 487 million, and CNY 555 million for 2025 to 2027 [4]

1Q25 业绩符合我们预期 巨星农牧公布1Q25 业绩：1Q25 营收同比+73.4%至16.45 亿元，归母净利同比+2.68 亿元至1.3 亿元， 1Q25 商品猪成本持续下降，出栏量、销售均价较同期增加，支撑利润上行。公司业绩符合我们预期。 发展趋势 1Q25 公司生猪销量同比快速增长，以商品猪销售为主。1）收入端，1Q25生猪销售收入15.22 亿元，公 司收入增长因商品猪出栏量价均同比增长。 维持2025/26 年净利润预测4.7/8.6 亿元。当前股价对应25/26 年23/13 倍P/E，维持跑赢行业评级。维持 目标价23 元，对应2025/26 年25/14 倍P/E，对应9%上行空间。 风险 非瘟等动物疫病风险；公司出栏低于预期风险；饲料成本上涨风险。 出栏重回扩张通道，较低成本构建高质量发展基础。1）降本增效：公司制定2025 年商品猪完全成本目 标13 元/千克以内，我们判断随公司产能爬坡，叠加技术创新及管理优化，成本控制目标具备达成基 础。2）资金稳健：轻资产养殖模式叠加低成本优势，资金状况有望保持稳健。公司坚持多种形式的、 轻资产为主的高质量种场发展模式，以及高质量寄养为主的育肥发展 ...

Core Viewpoint - The company reported a decline in revenue and net profit for 2024, primarily due to falling potash prices, but showed significant recovery in Q1 2025 with substantial growth in both revenue and profit [1][2][3]. Financial Performance - In 2024, the company achieved revenue of 3.548 billion yuan, a year-on-year decrease of 8.97%, and a net profit of 950 million yuan, down 23.05% [1][2]. - The adjusted net profit attributable to the parent company was 892 million yuan, reflecting a 30.00% decline year-on-year, with basic earnings per share at 1.04 yuan [1][3]. - For Q1 2025, the company reported revenue of 1.213 billion yuan, a remarkable increase of 91.47%, and a net profit of 384 million yuan, up 373.53% year-on-year [1][3]. Potash Production and Pricing - The company produced 1.8154 million tons of potash in 2024, marking a 10.24% increase, with sales volume reaching 1.7414 million tons, up 8.42% [2]. - The average selling price of potash for the company in 2024 was 1,989.47 yuan per ton, down 17.04% year-on-year, contributing to a 10.06% decline in potash business revenue [2]. - As of April 27, 2025, the domestic market price for potash had risen to 2,900 yuan per ton, reflecting a 12.84% increase since the beginning of 2025 and a 33.95% increase from the March 2024 low [3]. Resource and Capacity Expansion - The company is a leading player in the potash industry, with significant resources in Laos, holding over 1 billion tons of pure potassium chloride reserves [4]. - Current production capacity stands at 3 million tons per year, with plans to expand through additional projects [4]. - The company is also diversifying its operations by developing non-potash industries, enhancing overall resource utilization and economic benefits [4]. Earnings Forecast - The projected earnings per share (EPS) for 2025 and 2026 are 1.98 yuan and 2.65 yuan, respectively, with corresponding price-to-earnings (PE) ratios of 14.74 and 11.02 based on the closing price of 29.22 yuan on April 25 [5].

Core Viewpoint - The company reported a decline in revenue and net profit for FY 2024, with a significant drop in net profit year-over-year, while Q1 2025 showed a slight recovery in net profit despite a decrease in revenue [1][5]. Financial Performance - FY 2024 revenue was 15.65 billion yuan, with a net profit of 380 million yuan, reflecting a year-over-year decline of 0.21% and 78% respectively [1]. - Q1 2025 revenue was 3.48 billion yuan, with a net profit of 470 million yuan, showing a year-over-year decrease of 9.7% but a 6.4% increase in net profit [1]. - The company made impairment provisions of 298.62 million yuan, impacting net profit by 244.67 million yuan after tax [1]. Business Segments - Float glass and energy-saving glass revenue for FY 2024 was 6.86 billion yuan and 2.43 billion yuan, down 24% and 13% year-over-year respectively [2]. - The average selling price for float glass was 640 yuan per heavy box, down 19% year-over-year, while energy-saving glass saw a price increase of 9% to 776 yuan per square meter [2]. - Solar glass revenue increased by 69% to 5.75 billion yuan, with sales of 45.741 million square meters, benefiting from an increase in production capacity [2]. Profitability - The overall gross margin for FY 2024 was 15.5%, a decline of 9.5 percentage points year-over-year, primarily due to falling prices [3]. - Q1 2025 gross margin was 12%, down 14 percentage points year-over-year but up 6.5 percentage points quarter-over-quarter [3]. Capacity Expansion - As of the end of FY 2024, the company operated 24 float glass production lines with a daily capacity of 16,600 tons, 9 solar glass production lines with a capacity of 10,600 tons, and several other specialized production lines [4]. - The company has over 200 million tons of available silica sand resources, indicating strong scale and raw material advantages [4]. Long-term Outlook - The company is viewed positively for its long-term growth potential, maintaining a "buy" rating despite lowering profit forecasts for 2025-2027 [5]. - Projected net profits for 2025, 2026, and 2027 are 750 million yuan, 820 million yuan, and 1.53 billion yuan respectively, revised down from previous estimates [5].

Core Viewpoint - Anqi Yeast's Q1 2025 financial results exceeded expectations, with revenue growth driven by international markets while domestic performance remained stable [1][2][4] Financial Performance - Q1 2025 revenue reached 3.794 billion yuan, a year-on-year increase of 8.95%; net profit attributable to shareholders was 370 million yuan, up 16.02%; and net profit excluding non-recurring items was 337 million yuan, up 14.37% [1] - Gross margin for Q1 2025 was 25.97%, an increase of 1.31 percentage points year-on-year, despite depreciation pressures from new projects in Egypt and Russia [3] - The company reported a net profit margin of 10.2%, reflecting a year-on-year increase of 0.72 percentage points, indicating better-than-expected profitability [3] Regional Performance - Domestic revenue for Q1 2025 was 2.099 billion yuan, a slight decrease of 0.26% year-on-year, while international revenue was 1.684 billion yuan, showing a significant increase of 22.94% [2] - The company’s overseas revenue growth was primarily driven by strong performance in regions outside North America, which faced slight declines due to policy impacts [2][4] Product Performance - Revenue from yeast and deep processing products was 2.773 billion yuan, up 13.17% year-on-year, while sugar and packaging segments saw declines of 60.68% and 4.3%, respectively [2] - The newly disclosed food raw materials segment generated 434 million yuan, indicating a substantial year-on-year growth of 44.1% when combined with other businesses [2] Cost and Expense Management - The company experienced a decrease in molasses procurement costs by approximately 15%, contributing to improved gross margins [3] - Selling, general, and administrative expenses remained stable, with sales expense ratio slightly increasing due to overseas expansion efforts [3] Strategic Outlook - The company’s organizational restructuring in early 2025 is expected to enhance long-term business collaboration and efficiency, despite short-term challenges [4] - The ongoing expansion of production capacity is anticipated to support double-digit revenue growth in the coming years, with a focus on international markets as a key growth driver [4] Investment Recommendation - The company is positioned for growth with a target price of 44 yuan, corresponding to a PE ratio of approximately 25 times for 2025, reflecting a favorable investment opportunity at current valuation levels [5]

Investment Rating - The report maintains a "Buy" rating for the company, indicating a positive outlook for its stock performance relative to the market [7]. Core Views - The company reported a revenue of 5.35 billion yuan and a net profit of 760 million yuan for Q1 2025, showing a year-on-year increase of 12% in revenue but a slight decline of 3% in net profit [1]. - The company is expected to see a revenue growth of over 15% in 2025, driven by new customer orders and an increase in production capacity [2][4]. - The company is currently in a phase of expanding its production capacity, which is anticipated to enhance its international presence and operational efficiency in the medium to long term [3]. Summary by Sections Financial Performance - In Q1 2025, the company achieved a gross margin of 22.9%, down 5.5 percentage points year-on-year, primarily due to the ramp-up of new factories [1]. - The company’s net profit margin decreased by 2.3 percentage points to 14.3% in Q1 2025 [1]. Customer Orders and Market Position - The company has maintained strong relationships with major brands like Nike and Adidas, with expectations of stable orders from existing clients and significant growth from new clients [2]. - The company’s new collaboration with Adidas is expected to contribute to rapid order growth in 2025 [2]. Production Capacity and Efficiency - The company plans to expand its production capacity significantly, with a total capacity of 229 million pairs and a utilization rate of 97% expected in 2024 [3]. - The company is focusing on improving operational efficiency through training and automation, which is expected to enhance gross margins in the upcoming quarters [3]. Cash Flow and Inventory Management - As of Q1 2025, the company reported a 12.5% increase in inventory year-on-year, with inventory turnover days decreasing by 5.1 days to 74.1 days [4]. - The net operating cash flow for Q1 2025 was 1.21 billion yuan, approximately 1.6 times the net profit for the same period [4].

Investment Rating - The report maintains a "Buy" rating for the company, indicating a positive outlook for its stock performance in the coming months [7]. Core Views - The company reported a revenue of 5.35 billion yuan and a net profit of 760 million yuan for Q1 2025, showing a year-on-year increase of 12% in revenue but a slight decline of 3% in net profit [1]. - The company is expected to see a revenue growth of over 15% in 2025, driven by a significant increase in new customer orders and stable performance from existing clients [2]. - The company is undergoing capacity expansion with new factories coming online, which is anticipated to enhance its international production capabilities and support long-term growth [3]. - Cash flow and inventory management are reported to be stable, with inventory increasing by 12.5% year-on-year to 3.67 billion yuan [4]. Summary by Sections Financial Performance - In Q1 2025, the company achieved a gross margin of 22.9%, down 5.5 percentage points year-on-year, primarily due to the ramp-up of new factories [1]. - The company’s net profit margin decreased by 2.3 percentage points to 14.3% in Q1 2025 [1]. Customer Orders and Market Position - The company has maintained strong relationships with major brands like Nike and Adidas, with expectations of robust order growth from new clients in 2025 [2]. - The top five customers accounted for significant sales proportions, indicating a diversified yet concentrated customer base [2]. Capacity Expansion and Operational Efficiency - The company plans to increase its total production capacity to 229 million pairs in 2024, with a utilization rate of 97% [3]. - New factories are expected to contribute to a compound annual growth rate (CAGR) of approximately 15% in production volume from 2025 to 2026 [3]. Cash Flow and Inventory Management - As of Q1 2025, the company reported a net operating cash flow of 1.21 billion yuan, approximately 1.6 times its net profit for the same period [4]. - The inventory turnover days improved by 5.1 days year-on-year, indicating efficient inventory management practices [4]. Future Earnings Projections - The company’s projected net profits for 2025 to 2027 are estimated at 4.11 billion yuan, 4.76 billion yuan, and 5.49 billion yuan, respectively, with a PE ratio of 16 times for 2025 [4].

石家庄尚太科技股份有限公司 投资者关系活动记录表 编号：2025-003 | | □特定对象调研 □分析师会议 | | | | | --- | --- | --- | --- | --- | | 投资者关 | □媒体采访 □业绩说明会 | | | | | 系活动类 | □新闻发布会 □路演活动 | | | | | 别 | □现场参观 | | | | | | 其他（电话会议） | |  | | | 活动参与 | 电话会议 人 122 | | | | | 人员 | | | | | | 上市公司 | 董事、副总经理、董事会秘书 李龙侠 | | | | | 接待人员 | | | | | | 时间 | 2025 年 4 日 20:00 | 月 | | 28 | | 地点 | 公司北苏总部二楼会议室 | | | | | 形式 | 线上电话会议 | | | | | | 一、公司 2025 年第一季度经营情况介绍 | | | | | | （一）2025 年第一季度情况 | | | | | | 2025 年第一季度，公司北苏二期项目陆续投产，订单饱满保证 | | | | | | 了新增产能的充分释放，新增产能快速转化为销售订 ...

Operating Overview - The company reported a total operating revenue of 11.278 billion yuan in 2024, an increase of 15.54% year-on-year. However, the net profit attributable to shareholders was 317 million yuan, a decrease of 24.11% year-on-year, indicating challenges in profitability despite revenue growth [1] Profit Analysis - The gross profit margin was 5.13%, down 26.14% year-on-year, while the net profit margin was 2.9%, down 33.45% year-on-year. This significant decline reflects pressure on cost control and product pricing [2] Quarterly Performance - In the fourth quarter, total operating revenue was 3.44 billion yuan, an increase of 22.99% year-on-year, but the net profit attributable to shareholders was 115 million yuan, a decrease of 7.05% year-on-year. The non-recurring net profit was 94.42 million yuan, down 21.11% year-on-year, further confirming the company's profit difficulties [3] Assets, Liabilities, and Cash Flow - Accounts receivable at the end of the reporting period amounted to 2.102 billion yuan, an increase of 40.66% year-on-year, indicating potential difficulties in cash collection that may impact cash flow [4] - Operating cash flow per share was 0.14 yuan, an increase of 112.88% year-on-year. However, the average operating cash flow over the past three years relative to current liabilities was -2.96%, suggesting caution regarding overall cash flow status [5] - Interest-bearing debt was 1.257 billion yuan, an increase of 202.83% year-on-year, which may exert pressure on the company's future debt repayment capacity [6] Costs and Expenses - Total selling, administrative, and financial expenses amounted to 115 million yuan, accounting for 1.02% of revenue, an increase of 7.85% year-on-year. Notably, financial expenses increased by 126.45%, primarily due to a decrease in interest income compared to the previous year [7] Development and Strategy - The company achieved external sales of 2.09 million tons in 2024, with a sales volume growth of 22%. It maintains good cooperation with key customers, particularly in the self-owned brand and new energy vehicle customer segments [8] - New production capacity was affected by low utilization rates in the early stages of production in 2024, leading to a mismatch between operating profit and sales revenue growth. The company plans to establish new processing bases in Shucheng, Wuhu, and Loudi to promote capacity expansion and production line upgrades [9]

Summary of the Conference Call for Morning Bio (2025 Q1) Company Overview - The conference call pertains to Morning Bio, a company involved in the production and sale of various plant extracts, including chili red, lutein, steviol glycosides, and cottonseed products. Key Points and Arguments Chili Red Sales and Pricing - Chili red sales volume increased by approximately 30% year-on-year in Q1 2025, reaching over 3,000 tons, with an expected annual sales volume between 11,000 to 12,000 tons [2][6] - Current chili red price is at its lowest in nearly a decade, around 120,000 yuan per ton, but the company maintains a reasonable gross margin through cost-plus pricing [2][4][5] - The company anticipates a 10% growth in chili red sales for the year, contingent on raw material cost trends [6] Chili Extract Market Dynamics - Chili extract prices are also at historical lows, with domestic production shifting back to Yunnan due to cost advantages, leading to a more than doubling of sales volume in Q1 [2][7] - The company aims to increase its market share to over 50% through large-scale production and cost reduction strategies [2][8] Lutein Product Performance - Food-grade lutein sales grew by approximately 50% year-on-year, while feed-grade lutein is expected to see minimal growth due to market oversupply [2][9] - The market for lutein is characterized by excess supply, leading to lower prices and potentially reduced profits compared to the previous year [11][12] Steviol Glycosides Growth - Steviol glycosides are experiencing rapid growth primarily due to increased market share, with production efficiency significantly higher than competitors [2][13][15] - The company has optimized its production process, achieving over 95% yield, which contributes to its cost advantage [15] Cottonseed Business Recovery - The cottonseed business turned profitable in Q1 2025, with most cottonseed already procured and market conditions improving [2][16][17] - The company has locked in orders for over 99% of its products, expecting profit realization in Q2 and Q3 to mirror Q1 performance [17][18] Research and Development - R&D expenses in Q1 were at normal levels, focusing on efficiency improvements, new product development, and various health-related sectors [20] Capacity Expansion Plans - The company is expanding its production capacity, including a new health food production line expected to be operational by mid-2025 [21][22] International Market and Trade Impact - Approximately 40% of the company's plant extract business is exported, primarily to Asia, Europe, and South America, with minimal impact from US-China trade tensions due to prior adjustments [24][25] Financial Outlook - The company expects a significant improvement in overall profitability for 2025, with cottonseed business projected to contribute nearly 200 million yuan in incremental revenue [26] - Despite current low prices across products, a reversal in performance is anticipated, with profits expected to gradually improve over the next few years [26] Additional Important Insights - The company is currently at an early turning point in its business cycle, with expectations of gradual recovery in product prices and profitability in the coming years [26]